QA108 Phase III Study in Subjects With Intermediate AMD

Clinical trial NCT07189169 · RECRUITING

Trial details

NCT number: NCT07189169
Sponsor: Smilebiotek Zhuhai Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Intermediate Age-Related Macular Degeneration

Start date: 2025-07-08
Primary completion: 2027-03-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.